Max Hodak to discuss screen-free interfaces at TechCrunch Disrupt 2026
Science Corporation CEO Max Hodak will present his vision for brain-computer interfaces at TechCrunch Disrupt 2026. His company is advancing biohybrid brain-computer technology, including a retinal implant that has restored vision in some patients. Hodak will argue that the next era of technology will move beyond screens.
Hodak's engineering background traces back to childhood programming and biomedical studies at Duke, where he worked in Miguel Nicolelis's brain-computer interface laboratory. Before Neuralink, he co-founded Transcriptic, a robotic cloud lab for life sciences, and later launched Science Corporation in 2021 to pursue neural engineering applications.
The company's PRIMA implant has demonstrated clinical success, restoring sight in patients with severe vision loss through a camera-equipped glasses system that transmits images to a retinal chip. Science Corporation has raised $230 million at a $1.5 billion valuation, with ongoing research exploring seizure prediction, brain cell repair, and potential treatments for Parkinson's disease. Hodak will present these developments at TechCrunch Disrupt, running October 13-15 at Moscone West in San Francisco.
Brain-computer interfaces could fundamentally reshape how people interact with technology, potentially benefiting those with vision loss, mobility impairments, or neurological conditions like Parkinson's. If screen-free interfaces mature, they may alter daily computing habits for millions, though accessibility and affordability remain open questions. Widespread adoption could also raise privacy and safety considerations as neural data becomes more integrated into consumer technology. The technology's trajectory may depend on clinical trial outcomes and public acceptance over the coming years.